SARS-CoV-2 Infections Among Children in the Biospecimens from Respiratory Virus-Exposed Kids (BRAVE Kids) Study.
dc.contributor.author | Hurst, Jillian H | |
dc.contributor.author | Heston, Sarah M | |
dc.contributor.author | Chambers, Hailey N | |
dc.contributor.author | Cunningham, Hannah M | |
dc.contributor.author | Price, Meghan J | |
dc.contributor.author | Suarez, Liliana | |
dc.contributor.author | Crew, Carter G | |
dc.contributor.author | Bose, Shree | |
dc.contributor.author | Aquino, Jhoanna N | |
dc.contributor.author | Carr, Stuart T | |
dc.contributor.author | Griffin, S Michelle | |
dc.contributor.author | Smith, Stephanie H | |
dc.contributor.author | Jenkins, Kirsten | |
dc.contributor.author | Pfeiffer, Trevor S | |
dc.contributor.author | Rodriguez, Javier | |
dc.contributor.author | DeMarco, C Todd | |
dc.contributor.author | De Naeyer, Nicole A | |
dc.contributor.author | Gurley, Thaddeus C | |
dc.contributor.author | Louzao, Raul | |
dc.contributor.author | Cunningham, Coleen K | |
dc.contributor.author | Steinbach, William J | |
dc.contributor.author | Denny, Thomas N | |
dc.contributor.author | Lugo, Debra J | |
dc.contributor.author | Moody, M Anthony | |
dc.contributor.author | Permar, Sallie R | |
dc.contributor.author | Rotta, Alexandre T | |
dc.contributor.author | Turner, Nicholas A | |
dc.contributor.author | Walter, Emmanuel B | |
dc.contributor.author | Woods, Christopher W | |
dc.contributor.author | Kelly, Matthew S | |
dc.date.accessioned | 2021-01-04T20:54:16Z | |
dc.date.available | 2021-01-04T20:54:16Z | |
dc.date.issued | 2020-09-01 | |
dc.date.updated | 2021-01-04T20:54:15Z | |
dc.description.abstract | BACKGROUND: Children with SARS-CoV-2 infection typically have mild symptoms that do not require medical attention, leaving a gap in our understanding of the spectrum of illnesses that the virus causes in children. METHODS: We conducted a prospective cohort study of children and adolescents (<21 years of age) with a SARS-CoV-2-infected close contact. We collected nasopharyngeal or nasal swabs at enrollment and tested for SARS-CoV-2 using a real-time PCR assay. RESULTS: Of 382 children, 289 (76%) were SARS-CoV-2-infected. SARS-CoV-2-infected children were more likely to be Hispanic (p<0.0001), less likely to have a history of asthma (p=0.009), and more likely to have an infected sibling contact (p=0.0007) than uninfected children. Children ages 6-13 years were frequently asymptomatic (38%) and had respiratory symptoms less often than younger children (30% vs. 49%; p=0.008) or adolescents (30% vs. 59%; p<0.0001). Compared to children ages 6-13 years, adolescents more frequently reported influenza-like (61% vs. 39%; p=0.002), gastrointestinal (26% vs. 9%; p=0.003), and sensory symptoms (43% vs. 9%; p<0.0001), and had more prolonged illnesses [median (IQR) duration: 7 (4, 12) vs. 4 (3, 8) days; p=0.004]. Despite the age-related variability in symptoms, we found no differences in nasopharyngeal viral load by age or between symptomatic and asymptomatic children. CONCLUSIONS: Hispanic ethnicity and an infected sibling close contact are associated with increased SARS-CoV-2 infection risk among children, while a history of asthma is associated with decreased risk. Age-related differences in the clinical manifestations of SARS-CoV-2 infection must be considered when evaluating children for COVID-19 and in developing screening strategies for schools and childcare settings. | |
dc.identifier.uri | ||
dc.language | eng | |
dc.publisher | Cold Spring Harbor Laboratory | |
dc.relation.ispartof | medRxiv | |
dc.relation.isversionof | 10.1101/2020.08.18.20166835 | |
dc.title | SARS-CoV-2 Infections Among Children in the Biospecimens from Respiratory Virus-Exposed Kids (BRAVE Kids) Study. | |
dc.type | Journal article | |
duke.contributor.orcid | Hurst, Jillian H|0000-0001-5079-9920 | |
duke.contributor.orcid | Heston, Sarah M|0000-0001-6150-1149 | |
duke.contributor.orcid | Cunningham, Coleen K|0000-0002-7725-3052 | |
duke.contributor.orcid | Moody, M Anthony|0000-0002-3890-5855 | |
duke.contributor.orcid | Rotta, Alexandre T|0000-0002-4406-2276 | |
duke.contributor.orcid | Woods, Christopher W|0000-0001-7240-2453 | |
duke.contributor.orcid | Kelly, Matthew S|0000-0001-8819-2315 | |
pubs.organisational-group | School of Medicine | |
pubs.organisational-group | Duke Global Health Institute | |
pubs.organisational-group | Pathology | |
pubs.organisational-group | Pediatrics, Infectious Diseases | |
pubs.organisational-group | Duke | |
pubs.organisational-group | University Institutes and Centers | |
pubs.organisational-group | Institutes and Provost's Academic Units | |
pubs.organisational-group | Clinical Science Departments | |
pubs.organisational-group | Pediatrics | |
pubs.organisational-group | Duke Human Vaccine Institute | |
pubs.organisational-group | Medicine, Duke Human Vaccine Institute | |
pubs.organisational-group | Institutes and Centers | |
pubs.organisational-group | Medicine | |
pubs.organisational-group | Immunology | |
pubs.organisational-group | Basic Science Departments | |
pubs.organisational-group | Molecular Genetics and Microbiology | |
pubs.organisational-group | Duke Innovation & Entrepreneurship | |
pubs.organisational-group | Initiatives | |
pubs.organisational-group | Duke Clinical Research Institute | |
pubs.organisational-group | Pediatrics, Primary Care Pediatrics | |
pubs.organisational-group | Staff | |
pubs.organisational-group | Pediatrics, Critical Care Medicine | |
pubs.publication-status | Published online |